Patents Assigned to Cymra Life Sciences Limited
  • Publication number: 20240131038
    Abstract: The present disclosure relates generally to pharmaceutical compositions comprising cannabidiol (CBD), ?-9-tetrahydrocannabinol (THC) and linalool. In some embodiments, the pharmaceutical compositions are useful in the treatment of an inflammatory condition, e.g., useful for the treatment of pain.
    Type: Application
    Filed: December 6, 2021
    Publication date: April 25, 2024
    Applicant: Cymra Life Sciences Limited
    Inventors: Joel Ernest George Hardy, Simon Kenneth Pettinger, John Montgomery, Matthew Turner